Secukinumab shows positive effects in HS at 52 weeks
Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...
Secukinumab shows positive effects in HS at 52 weeks
High stress scores seen in patients with inflammatory skin diseases
Alternative medicine use common in HS patients
Adalimumab Tx for HS safe to continue through surgery